Bioequivalence and Bioavailability Forum • Statistical Issue (significant Formulation, Period and seq.)

Statistical Issue (significant Formulation, Period and seq.) [Regulatives / Guidelines]

posted by Dipesh Jayswal – 2007-05-10 15:22 (6988 d 23:58 ago) – Posting: # 718
Views: 13,565

Dear Imran,

u will get answers to ur questions on page no. 23 of below linked pdf document.

www.egagenerics.com/doc/zanen-biogenerics.pdf

I hope it will help u out to understand BA/BE.

Regards,
Dipesh

Complete thread:

Statistical Issue (significant Formulation, Period and seq.) Imran 2007-04-20 07:22 [Regulatives / Guidelines]
- Statistical Issue (significant Formulation, Period and seq.) usfda_emea 2007-05-05 09:12
- significant Formulation and Period effects Helmut 2007-05-07 14:42
- Statistical Issue (significant Formulation, Period and seq.)Dipesh Jayswal 2007-05-10 13:22
  - normalised Cmax Imran 2007-05-25 13:08
    - normalised Cmax Helmut 2007-06-30 14:57